{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:10:43Z","timestamp":1783098643856,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.prp.2026.156395","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:32:44Z","timestamp":1770507164000},"page":"156395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism"],"prefix":"10.1016","volume":"280","author":[{"given":"Jun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156395_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a Cancer J. Clinicians"},{"key":"10.1016\/j.prp.2026.156395_bib2","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2174\/0115701808241219230923154750","article-title":"A review of the azasteroid-type 5-alpha reductase inhibitors for the management of benign prostatic hyperplasia","volume":"21","author":"Chandra","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.prp.2026.156395_bib3","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","article-title":"Treatment effects in prostate cancer","volume":"31","author":"Evans","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156395_bib4","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, A.N. Giaquinto, Cancer statistics, 2024, 74 (2024) 12-49.","DOI":"10.3322\/caac.21820"},{"key":"10.1016\/j.prp.2026.156395_bib5","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2174\/1570180819666220819150351","article-title":"Research progress in regulation of ferroptosis by epigallocatechin-3- gallate in tumor cells","volume":"20","author":"Yan","year":"2023","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.prp.2026.156395_bib6","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2026.156395_bib7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2026.156395_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13008-023-00103-9","article-title":"Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma","volume":"18","author":"Yang","year":"2023","journal-title":"Cell Div."},{"key":"10.1016\/j.prp.2026.156395_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176894","article-title":"GDF15 attenuates sepsis-induced myocardial dysfunction by inhibiting cardiomyocytes ferroptosis via the SOCS1\/GPX4 signaling pathway","volume":"982","author":"Li","year":"2024","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2026.156395_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177127","article-title":"Metformin inhibits migration and epithelial-to-mesenchymal transition in non-small cell lung cancer cells through AMPK-mediated GDF15 induction","volume":"985","author":"Zhou","year":"2024","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2026.156395_bib11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/annonc\/mdu120","article-title":"GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma","volume":"25","author":"Yang","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2026.156395_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbrc.2020.03.079","article-title":"GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression","volume":"526","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156395_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156395_bib14","article-title":"The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2026.156395_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117366","article-title":"METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3\/AKT pathway and synergizes with PARP inhibitor","volume":"179","author":"Chen","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2026.156395_bib16","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.7150\/jca.42338","article-title":"The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation","volume":"11","author":"Yuan","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2026.156395_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103732","article-title":"Molecular mechanisms of ferroptosis and its role in prostate cancer therapy","volume":"176","author":"Wang","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.prp.2026.156395_bib18","article-title":"The functional roles of m6A modification in prostate cancer","volume":"17","author":"Zhang","year":"2023"},{"key":"10.1016\/j.prp.2026.156395_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/cr.2017.10","article-title":"Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.prp.2026.156395_bib20","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, K.D. Miller, Cancer Statistics, 2021, 71 (2021) 7-33.","DOI":"10.3322\/caac.21654"},{"key":"10.1016\/j.prp.2026.156395_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41419-021-04181-x","article-title":"Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156395_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-023-01430-0","article-title":"Ferroptosis landscape in prostate cancer from molecular and metabolic perspective","volume":"9","author":"Liang","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156395_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41391-022-00583-w","article-title":"The role of ferroptosis in prostate cancer: a novel therapeutic strategy","volume":"26","author":"Wang","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.prp.2026.156395_bib24","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.2174\/0115701808291381240226094729","article-title":"A linear and nonlinear QSAR analysis of benzimidazole derivative XY123 in prostate cancer treatment","volume":"21","author":"Bing","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.prp.2026.156395_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2026.156395_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","article-title":"Ferroptosis inducers as promising radiosensitizer agents in cancer radiotherapy","volume":"17","author":"Fatemeh-Jalali","year":"2024","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.prp.2026.156395_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156395_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0006-291X(03)00823-4","article-title":"Dysregulated expression of MIC-1\/PDF in human prostate tumor cells","volume":"305","author":"Karan","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156395_bib29","article-title":"Role of GDF15 in methylseleninic acid-mediated inhibition of cell proliferation and induction of apoptosis in prostate cancer cells","volume":"14","author":"Zhang","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2026.156395_bib30","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/cam4.3850","article-title":"Growth and differentiation factor 15 and NF-\u03baB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection","volume":"10","author":"Rybicki","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2026.156395_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","article-title":"GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation","volume":"10","author":"Siddiqui","year":"2022","journal-title":"Bone Res."},{"key":"10.1016\/j.prp.2026.156395_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000535089","article-title":"Research progress on the role and mechanism of GDF15 in body weight regulation","volume":"17","author":"Dong","year":"2024","journal-title":"Obes. Facts"},{"key":"10.1016\/j.prp.2026.156395_bib33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00424-020-02459-1","article-title":"GDF15, an update of the physiological and pathological roles it plays: a review","volume":"472","author":"Assadi","year":"2020","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.prp.2026.156395_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00432-024-06036-2","article-title":"Suppressing GDF15 enhances the chemotherapeutic effect of 5 FU on MSI-H CRC by regulating the ferroptosis pathway SLC7A11\/GSH\/GPX4","volume":"151","author":"Huang Fu","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156395_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119904","article-title":"Interdependent roles for growth differentiation factor-15 (GDF15) and LIMS1 in regulating cell migration: implications for colorectal cancer metastasis","volume":"1872","author":"Kotsoni","year":"2025","journal-title":"Biochim Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.prp.2026.156395_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111457","article-title":"GDF15 enhances anoikis resistance and metastasis of gastric cancer through protective autophagy","volume":"124","author":"Gao","year":"2024","journal-title":"Cell Signal"},{"key":"10.1016\/j.prp.2026.156395_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4111\/icu.2020.61.4.411","article-title":"A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone","volume":"61","author":"Kang","year":"2020","journal-title":"Invest. Clin. Urol."},{"key":"10.1016\/j.prp.2026.156395_bib38","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1038\/s41598-017-17207-2","article-title":"Relevance of MIC-1 in the Era of PSA as a serum based predictor of prostate cancer: a critical evaluation","volume":"7","author":"Bansal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156395_bib39","article-title":"Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2026.156395_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biology13060391","article-title":"RNA binding by the m6A methyltransferases METTL16 and METTL3","volume":"13","author":"Mansfield","year":"2024","journal-title":"Biol."},{"key":"10.1016\/j.prp.2026.156395_bib41","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.7150\/thno.61178","article-title":"Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156395_bib42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s11010-024-05023-y","article-title":"METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms","volume":"479","author":"He","year":"2024","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.prp.2026.156395_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.31083\/j.fbl2903117","article-title":"YTHDF1 promotes proliferation and inhibits apoptosis of gastric cancer cells via upregulating TCF7 mRNA translation","volume":"29","author":"Li","year":"2024","journal-title":"Front Biosci."},{"key":"10.1016\/j.prp.2026.156395_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2025.07.006","article-title":"GDF15 activates the PI3K\/AKT pathway to mediate macrophage M2 polarization to promote prostate cancer resistance to docetaxel","volume":"185","author":"Li","year":"2025","journal-title":"Mol. Immunol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:40:31Z","timestamp":1771544431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S0344033826000464"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156395","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156395"}}